The Asia-Pacific Mitral & Tricuspid Valve-in-Valve/Valve-in-Ring Registry (AP ViV Registry)

Recruiting now

Conditions studied: Valve Disease, Heart

In brief

A retrospective and prospective, observational, multicenter cohort study of consecutive patients undergoing transcatheter mitral/tricuspid ViV or ViR procedure with balloon expandable valve across participating sites in Asia-Pacific.

Key facts

Study ID

NCT07058935

Run by

National Heart Centre Singapore

People needed

150

Starts

2025-03-17

Expected to finish

2035-12-01

Last updated by the study team

2025-07-10

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥ 21
• Had at least one documented Mitral valve-in-valve/valve-in-ring procedure done during the period of 1 Jan 2023 to current date. (Retrospective) OR Planned to undergo a Mitral valve-in-valve/valve-in-ring procedure. (Prospective) OR Had at least one documented Tricuspid valve-in-valve/valve-in-ring procedure done during the period of 1 Jan 2023 to current date. (Retrospective) OR Planned to undergo a Tricuspid valve-in-valve/valve-in-ring procedure. (Prospective)

You may not qualify if…

• Active endocarditis
• Any other conditions which investigator deems unsuitable for participation.

Where it is running

• National Heart Centre Singapore — Singapore, Singapore (enrolling)
• Prince of Wales Hospital — Hong Kong, Hong Kong
• Queen Elizabeth Hospital — Hong Kong, Hong Kong
• MGM Healthcare Pvt Ltd — Chennai, Tamil Nadu, India
• The Madras Medical Mission — Chennai, Tamil Nadu, India
• Waikato Hospital — Hamilton, New Zealand
• John Hunter Hospital — New Lambton Heights, Australia
• Ramathibodi Hospital — Bangkok, Thailand

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.